Ligand Pharmaceuticals LGND Increase Decrease In Intangible Assets Current
Increase Decrease In Intangible Assets Current at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIntangibleAssetsCurrent.
The official record: Ligand Pharmaceuticals’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's increase decrease in intangible assets current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's increase decrease in intangible assets current?
- Ligand Pharmaceuticals (LGND) reported increase decrease in intangible assets current of $0 in Q4 2025.
- What does increase decrease in intangible assets current mean?
- This metric tracks the net change in the current portion of intangible assets, reflecting acquisitions, disposals, or reclassifications during the period. It provides insight into the company's investment in intellectual property, patents, or licenses that are expected to be realized within a year. Monitoring this helps assess the company's strategy for maintaining its competitive edge through short-term asset turnover.